PhRMA board approves proposal to fend off ‘most favored nation’

At a virtual meeting held Sunday, the PhRMA board approved a package of drug cost control measures that are intended as an alternative to the Trump administration’s “most favored nation” Executive Order, pharma CEOs and lobbyists briefed on the meeting told BioCentury.

The board vote came less than 24 hours before a deadline President Donald Trump set for the industry to negotiate alternatives to most favored nation (MFN) (see “Trump Issues Drug Pricing Ultimatum to Biopharma CEOs”). ...